120 related articles for article (PubMed ID: 8295009)
21. Determination of radiochemical purity and pharmacokinetic parameters of 99mTc-sulphur colloid and 99mTc-tin colloid.
Jovanović V; Konstantinovska D; Milivojević K; Bzenić J
Nuklearmedizin; 1981 Dec; 20(6):279-82. PubMed ID: 7329810
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of technetium-99m-L,L-EC in renal transplant recipients: a comparative study with technetium-99m-MAG3 and iodine-125-OIH.
Stoffel M; Jamar F; Van Nerom C; Verbruggen A; Mourad M; Leners N; Squifflet JP; Beckers C
J Nucl Med; 1994 Dec; 35(12):1951-8. PubMed ID: 7989976
[TBL] [Abstract][Full Text] [Related]
23. [The radiolabeling property of oligonucleotide with 99mTc using NHS-MAG3 as a chelator].
Zhang C; Tan TZ; Kuang AR; Li YC; Zheng JG; Pan WM
Sichuan Da Xue Xue Bao Yi Xue Ban; 2004 Mar; 35(2):169-71. PubMed ID: 15071906
[TBL] [Abstract][Full Text] [Related]
24. Monoclonal antibodies labeled with rhenium-186 using the MAG3 chelate: relationship between the number of chelated groups and biodistribution characteristics.
van Gog FB; Visser GW; Klok R; van der Schors R; Snow GB; van Dongen GA
J Nucl Med; 1996 Feb; 37(2):352-62. PubMed ID: 8667076
[TBL] [Abstract][Full Text] [Related]
25. Validation of alternative methods of preparing 99mTc-MAG3.
Seetharaman S; Sosabowski MH; Ballinger JR
Appl Radiat Isot; 2007 Nov; 65(11):1240-3. PubMed ID: 17434313
[TBL] [Abstract][Full Text] [Related]
26. Preparation of 99mTc-MAG3: radiochemical purity is affected by the residence time of sodium chloride injection in a three-part syringe.
Waight CC; Beattie LA; O'Brien LM; Millar AM
Nucl Med Commun; 2006 Feb; 27(2):197-200. PubMed ID: 16404235
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of five miniature chromatography systems for determining labeling efficiency of technetium Tc 99m pentetate.
Robbins PJ
Am J Hosp Pharm; 1983 Apr; 40(4):629-33. PubMed ID: 6342380
[TBL] [Abstract][Full Text] [Related]
28. Effect of protein binding on renal extraction of 131I-OIH and 99mTc-labeled tubular agents.
Eshima D; Eshima L; Hansen L; Lipowska M; Marzilli LG; Taylor A
J Nucl Med; 2000 Dec; 41(12):2077-82. PubMed ID: 11138695
[TBL] [Abstract][Full Text] [Related]
29. Feasibility of fractionating MAG3 cold kit for cost reduction.
Thorson LM; Hung JC; Hollar BS
Nucl Med Commun; 1992 Nov; 13(11):832-7. PubMed ID: 1470426
[TBL] [Abstract][Full Text] [Related]
30. A new technique of 99mTc-ciprofloxacin kit preparation.
Kleisner I; Komarek P; Komarkova I; Konopkova M
Nuklearmedizin; 2002 Oct; 41(5):224-9. PubMed ID: 12418309
[TBL] [Abstract][Full Text] [Related]
31. Formulation of lyophilized single vial kit of N-N-Ethylene-L-Dicysteine (EC) for labeling with
Afshan A; Sohaib M; Jehangir M
Pak J Pharm Sci; 2017 Jul; 30(4):1289-1295. PubMed ID: 29039327
[TBL] [Abstract][Full Text] [Related]
32. Stability of stabilized 99mTc-D,L-HMPAO stored in vials and syringes.
Del Carmen Plancha-Mansanet M; Caballero-Calabuig E; Félix-Fontestad J; Reyes-Ojeda MD; Sopena-Novales P; Abreu-Sánchez P; Del Carmen Cano-Terol M; Sopena-Monforte R
J Nucl Med Technol; 2008 Dec; 36(4):213-6. PubMed ID: 19008289
[TBL] [Abstract][Full Text] [Related]
33. Time dependence of iprofenin-labeling with technetium Tc 99m.
Ponto JA; Ponto LL
Am J Hosp Pharm; 1981 Dec; 38(12):1939-41. PubMed ID: 7325178
[TBL] [Abstract][Full Text] [Related]
34. Tissular distributions and kinetics of two renal 99mTc-radiopharmaceuticals in rat.
Bonnin F; Petiet A; Petegnief Y; Colas-Linhart N; Bok B
Cell Mol Biol (Noisy-le-grand); 2001 May; 47(3):437-42. PubMed ID: 11441950
[TBL] [Abstract][Full Text] [Related]
35. Sources of radiochemical impurities in the 99mTc/S-unprotected MAG3 system.
Noll B; Johannsen B; Spies H
Nucl Med Biol; 1995 Nov; 22(8):1057-62. PubMed ID: 8998467
[TBL] [Abstract][Full Text] [Related]
36. Pharmacokinetic alteration of (99m)Tc-MAG3 using serum protein binding displacement method.
Nishi K; Kobayashi M; Nishii R; Shikano N; Takamura N; Kuga N; Yamasaki K; Nagamachi S; Tamura S; Otagiri M; Kawai K
Nucl Med Biol; 2013 Apr; 40(3):366-70. PubMed ID: 23312701
[TBL] [Abstract][Full Text] [Related]
37. Synthetic copolymer kit for radionuclide blood-pool imaging.
Bogdanov AA; Callahan RJ; Wilkinson RA; Martin C; Cameron JA; Fischman AJ; Brady TJ; Weissleder R
J Nucl Med; 1994 Nov; 35(11):1880-6. PubMed ID: 7965173
[TBL] [Abstract][Full Text] [Related]
38. Methods for MAG3 conjugation and 99mTc radiolabeling of biomolecules.
Wang Y; Liu G; Hnatowich DJ
Nat Protoc; 2006; 1(3):1477-80. PubMed ID: 17406438
[TBL] [Abstract][Full Text] [Related]
39. The effect of selected preparation variables on the radiochemical purity of 99mTc-sestamibi.
Norenberg JP; Vaidya MP; Hladik WB; Pathak DR; Born JL; Anderson TL; Carroll TR
J Nucl Med Technol; 2005 Mar; 33(1):34-41. PubMed ID: 15731019
[TBL] [Abstract][Full Text] [Related]
40. Dextrose solutions yield radiochemical impurities: the "sweet" scans.
Al-Enizi E; Kazem N; Owunwanne A; Collier BD; Mathew M
J Nucl Med Technol; 2003 Mar; 31(1):33-6. PubMed ID: 12624126
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
